SEI Investments’s Albany Molecular Research Inc AMRI Stock Holding History

SEI Investments’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-44	Closed	-$1K	–	3560
2017 Q2	$1K	Hold	44	–	–	﹤0.01%	3030
2017 Q1	$1K	Sell	44 -156	-78%	-$2.56K	﹤0.01%	2874
2016 Q4	$8K	Buy	200 +156	+355%	+$2.65K	﹤0.01%	2529
2016 Q3	$1K	Hold	44	–	–	﹤0.01%	2799
2016 Q2	$1K	Hold	44	–	–	﹤0.01%	2602
2016 Q1	$1K	Buy	+44	New	+$690	﹤0.01%	2477
2015 Q1	–	Sell	-64	Closed	-$1K	–	2441
2014 Q4	$1K	Buy	+64	New	+$1.18K	﹤0.01%	2174

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

SEI Investments's AMRI Position: Q3 2017 in Review

SEI Investments sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 44 shares — an estimated $1K sold.

SEI Investments first reported a position in AMRI in Q4 2014 and held it in 7 quarters. The position peaked at $8K in Q4 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

SEI Investments reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
SEI Investments sold 44 Albany Molecular Research Inc shares in Q3 2017, an estimated $1K.
SEI Investments first reported a position in Albany Molecular Research Inc in Q4 2014 and held it in 7 quarters.
SEI Investments's Albany Molecular Research Inc position peaked at $8K in Q4 2016.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on SEI Investments's 13F filing for Q3 2017, filed 6 Nov 2017.